185 related articles for article (PubMed ID: 173757)
1. Antibody-dependent cell-mediated cytotoxicity to target cells infected with type 1 and type 2 herpes simplex virus.
Shore SL; Black CM; Melewicz FM; Wood PA; Nahmias AJ
J Immunol; 1976 Jan; 116(1):194-201. PubMed ID: 173757
[TBL] [Abstract][Full Text] [Related]
2. The mononuclear cell in human blood which mediates antibody-dependent cellular cytotoxicity to virus-infected target cells. II. Identification as a K cell.
Melewicz FM; Shore SL; Ades EW; Phillips DJ
J Immunol; 1977 Feb; 118(2):567-73. PubMed ID: 65428
[TBL] [Abstract][Full Text] [Related]
3. The mononuclear cell in human blood which mediates antibody-dependent cellular cytotoxicity to virus-infected target cells. I. Identification of the population of effector cells.
Shore SL; Melewicz FM; Gordon DS
J Immunol; 1977 Feb; 118(2):558-66. PubMed ID: 190316
[TBL] [Abstract][Full Text] [Related]
4. Human monocyte-macrophage-mediated antibody-dependent cytotoxicity to herpes simplex virus-infected cells.
Kohl S; Starr SE; oleske JM; Shore SL; Ashman RB; Nahmias AJ
J Immunol; 1977 Mar; 118(3):729-35. PubMed ID: 191525
[TBL] [Abstract][Full Text] [Related]
5. Human natural killer cell recognition of herpes simplex virus type 1 glycoproteins: specificity analysis with the use of monoclonal antibodies and antigenic variants.
Bishop GA; Marlin SD; Schwartz SA; Glorioso JC
J Immunol; 1984 Oct; 133(4):2206-14. PubMed ID: 6206157
[TBL] [Abstract][Full Text] [Related]
6. Human cytotoxic T cell clones directed against herpes simplex virus-infected cells. II. Bifunctional clones with cytotoxic and virus-induced proliferative activities exhibit herpes simplex virus type 1 and 2 specific or type common reactivities.
Yasukawa M; Zarling JM
J Immunol; 1984 Nov; 133(5):2736-42. PubMed ID: 6207243
[TBL] [Abstract][Full Text] [Related]
7. Human polymorphonuclear leucocytes as mediators of antibody-dependent cellular cytotoxicity to herpes simplex virus-infected cells.
Oleske JM; Ashman RB; Kohl S; Shore SL; Starr SE; Wood P; Nahmias AJ
Clin Exp Immunol; 1977 Mar; 27(3):446-53. PubMed ID: 193661
[TBL] [Abstract][Full Text] [Related]
8. Spleen cell-mediated cytotoxicity of hamster cells transformed by Herpes simplex virus: evidence for virus-specific membrane antigen.
Lausch RN; Jones C; Christie D; Hay KA; Rapp F
J Immunol; 1975 Jan; 114(1 Pt 2):459-65. PubMed ID: 163859
[TBL] [Abstract][Full Text] [Related]
9. Protection of neonatal mice against herpes simplex virus infection: probable in vivo antibody-dependent cellular cytotoxicity.
Kohl S; Loo LS
J Immunol; 1982 Jul; 129(1):370-6. PubMed ID: 6282968
[TBL] [Abstract][Full Text] [Related]
10. Antibody-dependent cellular cytotoxicity to target cells infected with herpes simplex viruses: functional adequacy in the neonate.
Shore SL; Milgrom H; Wood PA; Nahmias AJ
Pediatrics; 1977 Jan; 59(1):22-8. PubMed ID: 190582
[TBL] [Abstract][Full Text] [Related]
11. Human natural killer cells limit replication of herpes simplex virus type 1 in vitro.
Fitzgerald PA; Mendelsohn M; Lopez C
J Immunol; 1985 Apr; 134(4):2666-72. PubMed ID: 2982949
[TBL] [Abstract][Full Text] [Related]
12. Antibody-dependent cellular cytotoxicity against cells infected with herpes simplex virus type 1 in Igh-1 disparate congenic mice.
Tamesis RR; Rodriguez A; Hoang-Xuan T; Foster CS
Ger J Ophthalmol; 1993 Aug; 2(4-5):218-23. PubMed ID: 8220102
[TBL] [Abstract][Full Text] [Related]
13. Heteroconjugate antibodies enhance cell-mediated anti-herpes simplex virus immunity.
Paya CV; McKean DJ; Segal DM; Schoon RA; Showalter SD; Leibson PJ
J Immunol; 1989 Jan; 142(2):666-71. PubMed ID: 2536060
[TBL] [Abstract][Full Text] [Related]
14. Functional heterogeneity among herpes simplex virus-specific human CD4+ T cells.
Yasukawa M; Inatsuki A; Horiuchi T; Kobayashi Y
J Immunol; 1991 Feb; 146(4):1341-7. PubMed ID: 1671404
[TBL] [Abstract][Full Text] [Related]
15. Antibodies against herpes simplex virus in a group of healthy humans without reactions to herpes simplex virus antigens in blasttransformation assays.
Møller-Larsen A
J Clin Lab Immunol; 1986 Jul; 20(3):121-7. PubMed ID: 3018253
[TBL] [Abstract][Full Text] [Related]
16. Reversal of SV40 tumor-mediated suppression of spleen cell cytotoxicity by antibody.
Prather SO; Lausch RN
J Immunol; 1977 Jan; 118(1):203-10. PubMed ID: 187698
[TBL] [Abstract][Full Text] [Related]
17. Inhibition by rheumatoid factor, anti-FC, and staphylococcal protein A of antibody-dependent cell-mediated cytolysis against Herpes simplex virus-infected cells.
Austin RM; Daniels CA
J Immunol; 1976 Aug; 117(2):602-7. PubMed ID: 181492
[TBL] [Abstract][Full Text] [Related]
18. Enhanced lysis of herpes simplex virus type 1-infected mouse cell lines by NC and NK effectors.
Colmenares C; Lopez C
J Immunol; 1986 May; 136(9):3473-80. PubMed ID: 2420891
[TBL] [Abstract][Full Text] [Related]
19. Immune interactions with cells infected with herpes simplex virus: antibodies to radioiodinated surface antigens.
Glorioso JC; Smith JW
J Immunol; 1977 Jan; 118(1):114-21. PubMed ID: 187696
[TBL] [Abstract][Full Text] [Related]
20. Herpes simplex virus-specific human cytotoxic T-cell colonies expressing either gamma delta or alpha beta T-cell receptor: role of accessory molecules on HLA-unrestricted killing of virus-infected targets.
Maccario R; Comoli P; Percivalle E; Montagna D; Locatelli F; Gerna G
Immunology; 1995 May; 85(1):49-56. PubMed ID: 7635521
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
